供体植入的CHIP在患有不明原因血细胞减少症的干细胞移植受者中很常见。
Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias.
作者信息
Gibson Christopher J, Kennedy James A, Nikiforow Sarah, Kuo Frank C, Alyea Edwin P, Ho Vincent, Ritz Jerome, Soiffer Robert, Antin Joseph H, Lindsley R Coleman
机构信息
Dana-Farber Cancer Institute, Boston, MA.
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; and.
出版信息
Blood. 2017 Jul 6;130(1):91-94. doi: 10.1182/blood-2017-01-764951. Epub 2017 Apr 26.
Abstract
There is an Inside Commentary on this article in this issue.
摘要
本期有一篇关于本文的内评。
相似文献
1
Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias.供体植入的CHIP在患有不明原因血细胞减少症的干细胞移植受者中很常见。
Blood. 2017 Jul 6;130(1):91-94. doi: 10.1182/blood-2017-01-764951. Epub 2017 Apr 26.
2
Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!成人血液系统恶性肿瘤的供者来源选择：2017 年，为所有患者寻找合适的供者！
Oncologist. 2017 Sep;22(9):1125-1134. doi: 10.1634/theoncologist.2017-0009. Epub 2017 May 25.
3
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.供者克隆性造血在异基因造血干细胞移植中的作用。
J Clin Oncol. 2019 Feb 10;37(5):375-385. doi: 10.1200/JCO.2018.79.2184. Epub 2018 Nov 7.
4
Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation.造血干细胞移植后供者来源血液系统恶性肿瘤的证据。
Biol Blood Marrow Transplant. 2006 May;12(5):511-7. doi: 10.1016/j.bbmt.2006.01.006.
5
Young and Restless: Expansion of Donor-Origin Mutant HSCs after Transplantation.年轻不设防：移植后供体源性突变 HSCs 的扩增。
Cell Stem Cell. 2020 Mar 5;26(3):305-306. doi: 10.1016/j.stem.2020.01.022.
6
Tissue-based chimerism analysis enhances detection of donor-derived neoplasia in allogeneic stem cell transplant patients.基于组织的嵌合分析可提高异基因干细胞移植患者中供体来源肿瘤的检测率。
Bone Marrow Transplant. 2017 Apr;52(4):634-637. doi: 10.1038/bmt.2016.332. Epub 2016 Dec 19.
7
Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.来自匹配的相关供体的阳性选择外周血CD34+祖细胞的异基因移植。
Bone Marrow Transplant. 1996 Dec;18(6):1081-6.
8
Second allografts for relapsed hematologic malignancies: feasibility of using a different donor.复发血液系统恶性肿瘤的二次同种异体移植：使用不同供体的可行性
Bone Marrow Transplant. 2005 Feb;35(3):261-4. doi: 10.1038/sj.bmt.1704761.
9
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.与双脐带移植相比，减低强度单倍体加单脐带移植：植入改善，无移植物抗宿主病，无复发生存率提高。
Haematologica. 2016 May;101(5):634-43. doi: 10.3324/haematol.2015.138594. Epub 2016 Feb 11.
10
Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.在成人中，以骨髓作为干细胞来源可改善无移植物抗宿主病、无复发的生存率。
Haematologica. 2016 Jun;101(6):764-72. doi: 10.3324/haematol.2015.138990. Epub 2016 Apr 1.
引用本文的文献
1
Allogeneic Transplantation for Older Adults.老年人的异体移植
Adv Exp Med Biol. 2025;1475:9-40. doi: 10.1007/978-3-031-84988-6_2.
2
Implications of Clonal Hematopoiesis in Hematological and Non-Hematological Disorders.克隆性造血在血液系统和非血液系统疾病中的意义
Cancers (Basel). 2024 Dec 9;16(23):4118. doi: 10.3390/cancers16234118.
3
Characterization of clonal dynamics using duplex sequencing in donor-recipient pairs decades after hematopoietic cell transplantation.使用双链测序技术在造血细胞移植数十年后对供受者对进行克隆动力学特征分析。
Sci Transl Med. 2024 Oct 23;16(770):eado5108. doi: 10.1126/scitranslmed.ado5108.
4
Influence of the Bone Marrow Microenvironment on Hematopoietic Stem Cell Behavior Post-Allogeneic Transplantation: Development of Clonal Hematopoiesis and Telomere Dynamics.同种异体移植后骨髓微环境对造血干细胞行为的影响：克隆性造血和端粒动力学的发展。
Int J Mol Sci. 2024 Sep 24;25(19):10258. doi: 10.3390/ijms251910258.
5
Hematopoietic stem cell transplantation: an Italian monocentric experience on the health assessment and eligibility of adult-related donors.造血干细胞移植：意大利单中心关于成人相关供体健康评估及合格性的经验
Front Oncol. 2024 May 30;14:1389068. doi: 10.3389/fonc.2024.1389068. eCollection 2024.
6
Clonal hematopoiesis in the setting of hematopoietic cell transplantation.造血干细胞移植背景下的克隆性造血。
Semin Hematol. 2024 Feb;61(1):9-15. doi: 10.1053/j.seminhematol.2024.01.011. Epub 2024 Feb 1.
7
Causes and consequences of clonal hematopoiesis.克隆性造血的原因和后果。
Blood. 2023 Dec 28;142(26):2235-2246. doi: 10.1182/blood.2023022222.
8
Donor Cell Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植后的供体细胞白血病
J Hematol. 2023 Jun;12(3):138-144. doi: 10.14740/jh1124. Epub 2023 Jun 30.
9
Clonal haematopoiesis and dysregulation of the immune system.克隆性造血与免疫系统失调。
Nat Rev Immunol. 2023 Sep;23(9):595-610. doi: 10.1038/s41577-023-00843-3. Epub 2023 Mar 20.
10
Measurable Residual Disease and Clonal Evolution in Acute Myeloid Leukemia from Diagnosis to Post-Transplant Follow-Up: The Role of Next-Generation Sequencing.从诊断到移植后随访的急性髓系白血病中的可测量残留病和克隆进化：下一代测序的作用
Biomedicines. 2023 Jan 26;11(2):359. doi: 10.3390/biomedicines11020359.
本文引用的文献
1
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.与TET2缺陷相关的克隆性造血加速小鼠动脉粥样硬化发展。
Science. 2017 Feb 24;355(6327):842-847. doi: 10.1126/science.aag1381. Epub 2017 Jan 19.
2
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.淋巴瘤自体干细胞移植后与不良预后相关的克隆性造血
J Clin Oncol. 2017 May 10;35(14):1598-1605. doi: 10.1200/JCO.2016.71.6712. Epub 2017 Jan 9.
3
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.老年患者的克隆性造血与治疗相关的髓系恶性肿瘤：一项概念验证性病例对照研究。
Lancet Oncol. 2017 Jan;18(1):112-121. doi: 10.1016/S1470-2045(16)30627-1. Epub 2016 Dec 4.
4
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study.白血病前期克隆性造血与治疗相关髓系肿瘤的风险：一项病例对照研究。
Lancet Oncol. 2017 Jan;18(1):100-111. doi: 10.1016/S1470-2045(16)30626-X. Epub 2016 Dec 3.
5
Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults.携带 AML 相关突变的克隆性造血在健康成年人中普遍存在。
Nat Commun. 2016 Aug 22;7:12484. doi: 10.1038/ncomms12484.
6
Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy.识别与干细胞动员不佳和供体来源恶性肿瘤相关的遗传和后天遗传因素。
Biol Blood Marrow Transplant. 2016 Nov;22(11):2100-2103. doi: 10.1016/j.bbmt.2016.08.002. Epub 2016 Aug 4.
7
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.一种用于血液系统恶性肿瘤的定制下一代测序临床检测方法的验证与实施
J Mol Diagn. 2016 Jul;18(4):507-15. doi: 10.1016/j.jmoldx.2016.02.003.
8
Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation.骨髓移植后克隆性造血引发的供体细胞白血病
Leukemia. 2016 Sep;30(9):1916-1920. doi: 10.1038/leu.2016.63. Epub 2016 Mar 15.
9
Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation.供体细胞衍生的血液系统恶性肿瘤：日本造血干细胞移植学会的一项调查。
Leukemia. 2016 Aug;30(8):1742-5. doi: 10.1038/leu.2016.23. Epub 2016 Feb 12.
10
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.供者特征对血液系统恶性肿瘤异基因供者移植后生存的影响。
Blood. 2016 Jan 14;127(2):260-7. doi: 10.1182/blood-2015-08-663823. Epub 2015 Nov 2.
Zotero 插件